Clinical Research
News & Careers
Search the Site
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login   

By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile


Oncothyreon Inc. 

2601 Fourth Avenue
Suite 500
Seattle  Washington  98121   U.S.A.
Phone: 206-801-2100 Fax: 206-801-2101



 Company News
Oncothyreon Inc. (ONTY) Announces Presentation Of ONT-10 Data At American Society of Clinical Oncology Annual Meeting 6/2/2014 7:27:28 AM
Oncothyreon Inc. (ONTY) And Celldex Therapeutics, Inc. (CLDX) Announce Collaboration For Combination Immunotherapy Clinical Trial Of ONT-10 And Varlilumab 5/29/2014 9:52:32 AM
Oncothyreon Inc. (ONTY) To Present At Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 6:29:40 AM
Oncothyreon Inc. (ONTY) Reports First Quarter 2014 Financial Results 5/2/2014 8:51:35 AM
Oncothyreon Inc. (ONTY) Announces First Quarter 2014 Financial Results Conference Call 4/24/2014 6:59:13 AM
Sentinel Oncology And Oncothyreon Inc. (ONTY) Collaborate To Develop And Commercialise Small Molecule Chk1 Inhibitors 4/22/2014 2:33:04 PM
Oncothyreon Inc. (ONTY) Announces Merck KGaA (MKGAF.PK), Darmstadt, Germany, Initiation Of Phase 3 Start2 Study With Tecemotide In Stage III Non-Small Cell Lung Cancer 4/7/2014 9:35:30 AM
Oncothyreon Inc. (ONTY) Reports Full Year And Fourth Quarter 2013 Financial Results 3/14/2014 6:23:56 AM
Oncothyreon Inc. (ONTY) Announces Full Year And Fourth Quarter 2013 Financial Results Conference Call 3/6/2014 6:58:17 AM
Oncothyreon Inc. (ONTY) To Present At Cowen and Company 34th Annual Health Care Conference 2/26/2014 6:39:35 AM